Hepatitis B virus infection

被引:222
作者
Chang, Mei-Hwei [1 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 100, Taiwan
关键词
hepatitis B virus; mother-to-infant transmission; chronic hepatitis B; hepatitis B e antigen; hepatitis B; immunoglogutin; hepatitis B vaccine;
D O I
10.1016/j.siny.2007.01.013
中图分类号
R72 [儿科学];
学科分类号
100202 [儿科学];
摘要
Hepatitis B virus (HBV) infection is a worldwide health problem and may cause acute, fulminant, chronic hepatitis, liver cirrhosis, or hepatocelullar carcinoma (HCC). Infection with HBV, in infancy or early childhood may lead to a high rate of persistent infection (2590%), while the rates are tower if infection occurs during adulthood (5-10%). In most endemic areas, infection occurs mainly during early childhood and mother-to-infant transmission accounts for approximately 50% of the chronic infection cases. Hepatitis B during pregnancy does not increase maternal mortality or morbidity or the risk of fetal complications. Approximately 90% of the infants of HBsAg carrier mothers with positive hepatitis B e-antigen (HBeAg) wilt become carriers if no immunoprophylaxis is given. Transptacental HBeAg may induce a specific non-responsiveness of helper T cells and HBcAg. Spontaneous HBeAg seroconversion to anti-HBe may develop with time but liver damage may occur during the process of the immune clearance of HBV and HBeAg. Mother-to-infant transmission of HBV from HBeAg negative but HBsAg positive mothers is the most important cause of acute or fulminant hepatitis B in infancy. Although antiviral agents are available to treat and avoid the complications of chronic hepatitis B, prevention of HBV infection is the best way for control. Screening for maternal HBsAg with/without HBeAg, followed by three to four doses of HBV vaccine in infancy and hepatitis B immunoglobutin (HBIG) within 24 h of birth is the most effective way to prevent HBV infection. In areas with,a low prevalence of HBV infection or with limited resources, omitting maternal screening but giving three doses of HBV vaccine universally in infancy can also produce good protective efficacy. The first universal HBV immunisation programme in the world was launched in Taiwan 22 years ago. HBV infection rates, chronicity rates, incidence of HCC and incidence of fulminant hepatitis in children have been effectively reduced. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:160 / 167
页数:8
相关论文
共 50 条
[1]
BARBERA C, 1994, HEPATOLOGY, V20, P287, DOI 10.1016/0270-9139(94)90175-9
[2]
INCIDENCE OF HEPATITIS-B VIRUS-INFECTIONS IN PRESCHOOL-CHILDREN IN TAIWAN [J].
BEASLEY, RP ;
HWANG, LY ;
LIN, CC ;
LEU, ML ;
STEVENS, CE ;
SZMUNESS, W ;
CHEN, KP .
JOURNAL OF INFECTIOUS DISEASES, 1982, 146 (02) :198-204
[3]
INCIDENCE OF HEPATITIS AMONG STUDENTS AT A UNIVERSITY IN TAIWAN [J].
BEASLEY, RP ;
HWANG, LY ;
LIN, CC ;
KO, YC ;
TWU, SJ .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1983, 117 (02) :213-222
[4]
Chronic hepatitis B in children after e antigen seroclearance: Final report of a 29-year longitudinal study [J].
Bortolotti, F ;
Guido, M ;
Bartolacci, S ;
Cadrobbi, P ;
Crivellaro, C ;
Noventa, F ;
Morsica, G ;
Moriondo, M ;
Gatta, A .
HEPATOLOGY, 2006, 43 (03) :556-562
[5]
Long term effect of alpha interferon in children with chronic hepatitis B [J].
Bortolotti, F ;
Jara, P ;
Barbera, C ;
Gregorio, GV ;
Vegnente, A ;
Zancan, L ;
Hierro, L ;
Crivellaro, C ;
Vergani, GM ;
Iorio, R ;
Pace, M ;
Con, P ;
Gatta, A .
GUT, 2000, 46 (05) :715-718
[6]
LONG-TERM OUTCOME OF CHRONIC TYPE-B HEPATITIS IN PATIENTS WHO ACQUIRE HEPATITIS-B VIRUS-INFECTION IN CHILDHOOD [J].
BORTOLOTTI, F ;
CADROBBI, P ;
CRIVELLARO, C ;
GUIDO, M ;
RUGGE, M ;
NOVENTA, F ;
CALZIA, R ;
REALDI, G .
GASTROENTEROLOGY, 1990, 99 (03) :805-810
[7]
THE SIGNIFICANCE OF SPONTANEOUS HEPATITIS-B E-ANTIGEN SEROCONVERSION IN CHILDHOOD - WITH SPECIAL EMPHASIS ON THE CLEARANCE OF HEPATITIS-B E-ANTIGEN BEFORE 3 YEARS OF AGE [J].
CHANG, MH ;
HSU, HY ;
HSU, HC ;
NI, YH ;
CHEN, JS ;
CHEN, DS .
HEPATOLOGY, 1995, 22 (05) :1387-1392
[8]
CHANG MH, 1989, CANCER-AM CANCER SOC, V64, P2377, DOI 10.1002/1097-0142(19891201)64:11<2377::AID-CNCR2820641130>3.0.CO
[9]
2-8
[10]
Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: The effect and problems [J].
Chang, MH ;
Chen, THH ;
Hsu, HM ;
Wu, TC ;
Kong, MS ;
Liang, DC ;
Ni, YH ;
Chen, CJ ;
Chen, DS .
CLINICAL CANCER RESEARCH, 2005, 11 (21) :7953-7957